Phoenix Molecular Pte Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Phoenix Molecular Pte Ltd - overview
Established
2014
Location
Singapore, -, Singapore
Primary Industry
Medical Devices & Equipment
About
Founded in 2014 and based in Singapore, Phoenix Molecular Pte Ltd operates as a developer and manufacturer of molecular diagnostic device for screening Zika virus.
Current Investors
Red Dot Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories, Medical Devices & Equipment
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Phoenix Molecular Pte Ltd - timeline of key events
Phoenix Molecular Pte Ltd - financials
| Fiscal Year Ended | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | 3,700 | 3,000 | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | (18.9%) | (100.0%) | - | - | - | - | - |
| EBITDA (USD) | (760) | (142,799) | (17,596) | (242,790) | (238,578) | (41,717) | (53,692) | (38,146) | - | - | - |
| Operating Income (USD) | (760) | (142,799) | (18,032) | (243,723) | (239,663) | (42,366) | (53,692) | (38,146) | - | - | - |
| Operating Margin | - | - | - | (6587.1%) | (7988.8%) | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | (6561.9%) | (7952.6%) | - | - | - | - | - | - |
| NET Income (USD) | (760) | (142,799) | (18,032) | (243,723) | (239,663) | (42,366) | (53,692) | (38,146) | - | - | - |
| % Net Margin | - | - | - | (6587.1%) | (7988.8%) | - | - | - | - | - | - |
Phoenix Molecular Pte Ltd - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.